SSDV Annual Congress 2025
< back to event website
Converia – Conference Management Software

Detailed contribution information

Back to list

Contribution title Case Report: Off-label Treatment with Omalizumab in Bullous Pemphigoid Unresponsive to First-line Therapy
Authors
  1. Maverick John Hofer Kantonsspital Aarau Presenter
  2. Beda Mühleisen Universitätsspital Basel
  3. Lukas Krähenbühl Kantonsspital Aarau AG
Form of presentation Poster
Topic
  • 1.1 Inflammatory and immune-mediated dermatoses